Strategic Research Programme: Cancer Cell Targeting in Myeloma and Melanoma (MyMe) Vrije Universiteit Brussel
R&D centraal, Laboratory of Molecullar and Cellular Therapy, Immunomodulation in Chronic Inflammatory Diseases, Hematology, Basic (bio-) Medical Sciences, Physiology
Anti-tumor vaccination requires the identification of target antigens on resistant tumor subpopulations, adequate immune competence of the patients and the availability of efficient vaccination techniques.